Every Form 4 that Enova Intl Inc (ENVA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ENVA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ENVA filings page.
Enova International, Inc. (ENVA) reported that Executive Chairman David Fisher exercised and sold company stock in paired transactions. On August 25 and 26, 2026, he exercised non-qualified stock options for a total of 18,569 shares of common stock at an exercise price of $20.73 per share and acquired the same number of common shares. On those same dates, he sold all 18,569 shares in open-market transactions at weighted average prices of $244.01 (range $241.46–$251.20) and $239.16 (range $236.29–$244.93) per share, pursuant to a Rule 10b5-1 trading plan adopted on January 30, 2026. The exercised options, which were granted in tandem with a limited stock appreciation right, carry an exercise price of $20.73 and were scheduled to expire on February 11, 2027.
Enova International reported an equity compensation grant to its General Counsel and Secretary, Sean Rahilly. He received 1,453 non-qualified stock options with a tandem limited stock appreciation right, at an exercise price of $257.79 per share, expiring on August 5, 2033. The options vest in substantially equal one-third increments on August 5 of 2027, 2028, and 2029, contingent on continued employment, and are exercisable for common stock subject to change-in-control and qualifying offer conditions described in the grant.
Enova International Chief Executive Officer Steven E. Cunningham received a grant of 7,359 non-qualified stock options paired with limited stock appreciation rights to acquire Enova common stock at an exercise price of $257.79 per share. These awards vest in three substantially equal annual installments on August 5, 2027, 2028 and 2029 and expire on August 5, 2033. The SAR component is exercisable only in connection with a defined Change in Control and a qualifying offer, with value based on the excess of an Offer Value Per Share over the option exercise price.
Enova International, Inc.'s Executive Chairman David Fisher received a grant of 6,190 non-qualified stock options on August 5, 2026, with an exercise price of $257.79 per share and expiration on August 5, 2033. The options vest in three equal annual installments from 2027 to 2029 and are paired with a limited stock appreciation right exercisable only upon a qualifying change in control and offer, as defined in the grant agreement.
Enova International reported that CFO Cornelis Scott received a grant of 1,500 non-qualified stock options with a tandem limited stock appreciation right, exercisable at $257.79 per share and expiring on August 5, 2033. The options vest in substantially equal one-third increments on August 5, 2027, August 5, 2028, and August 5, 2029, subject to continued employment. The related SAR becomes exercisable only for a 30-day period following a Change in Control and a qualifying offer, with value based on the excess of the Offer Value Per Share over the option exercise price.
Enova International granted Chief Strategy Officer Kirk Chartier a non-qualified stock option with a tandem limited stock appreciation right covering 2,095 shares of common stock at an exercise price of $257.79 per share. The option expires on August 5, 2033 and vests in substantially equal one-third increments on August 5, 2027, August 5, 2028 and August 5, 2029, contingent on continued employment. The SAR becomes exercisable only after a defined Change in Control and qualifying Offer, and pays the excess of the Offer Value Per Share over the exercise price on the shares exercised.
Veltre Maria reported acquisition or exercise transactions in this Form 4 filing.
Enova International, Inc. director Maria Veltre reported an equity compensation award of 772 Restricted Stock Units (RSUs) tied to common stock on August 5, 2026. The RSUs have no purchase price and 100% are scheduled to vest on August 5, 2027, contingent on her continued service on the board. Following this grant, she is reported as directly holding 772 units/shares.
Enova International Executive Chairman David Fisher reported an exercise-and-sell sequence over July 14–15, 2026. He exercised options for a total of 28,500 common shares at $20.73 per share and sold the same number in open-market transactions at weighted-average prices of $231.454 and $231.5061 per share.
Following these transactions, Fisher directly holds 306,444 Enova common shares and 184,682 non-qualified stock options with a $20.73 exercise price expiring on February 11, 2027. The options vested in substantially equal one-third increments in 2021, 2022, and 2023.
Enova International, Inc. director Mark Tebbe reported an open-market sale of 20,000 shares of common stock on June 18, 2026. The shares were sold at a weighted average price of $201.368 per share in multiple trades executed between $200.325 and $202.26. Following this transaction, Tebbe directly holds 50,029 Enova shares.
Enova International Executive Chairman David Fisher exercised stock options and sold shares in a combined transaction. He exercised options to acquire 33,060 shares of common stock at an exercise price of $20.73 per share, then sold 33,060 shares in an open-market sale at a weighted average price of $199.0514 per share, with individual trades executed between $193.85 and $202.70. Following these transactions, he directly holds 306,444 shares of Enova International common stock.
Enova International director William M. Goodyear reported two stock dispositions. On June 16, 2026, he completed an open-market sale of 3,500 common shares at a weighted average price of $188.0157 per share, executed in multiple trades between $186.53 and $190.17. Following this sale, he directly owned 50,820 shares of Enova common stock.
Earlier, on June 12, 2026, Goodyear made a bona fide gift of 8,437 shares of common stock with a reported transaction price of $0 per share, reflecting that no consideration was received for the transfer.
Enova International, Inc. director William M. Goodyear reported an open-market sale of 5,983 shares of common stock on June 1, 2026 at a weighted average price of $163.1287 per share. Following this transaction, he directly holds 62,757 shares.
The sale was executed in multiple trades at prices ranging from $161.28 to $164.83, with the reported price reflecting the weighted average across those trades.
Enova International, Inc. director Linda Johnson Rice reported an open-market sale of company stock. On May 29, 2026, she sold 1,300 shares of Enova common stock at a weighted average price of $161.1968 per share in multiple trades between $161.1102 and $161.47.
Following this transaction, she holds 6,277 shares of Enova common stock directly.
Enova International Executive Chairman David Fisher reported option exercises paired with share sales. On May 21–22, 2026, he exercised options for 10,256 shares of common stock at an exercise price of $20.73 per share and sold the same number of shares in open-market transactions.
The reported weighted average sale prices were $160.3724 and $158.4467 per share across multiple trades. Following these transactions, Fisher directly holds 306,444 shares of Enova common stock, indicating he retained a substantial equity position after this exercise-and-sell activity.
Enova International, Inc. director William M. Goodyear sold 6,231 shares of common stock in an open-market transaction on May 18, 2026. The shares were sold at a weighted average price of $166.0776 per share in multiple trades between $165.60 and $167.235.
Following this sale, Goodyear directly holds 68,740 Enova shares. The transaction reflects a partial reduction of his position while maintaining a substantial remaining stake in the company.
Enova International’s Chief Financial Officer Cornelis Scott reported routine equity compensation activity. He received a grant of 2,176 non-qualified stock options with a $166.88 exercise price, expiring on May 13, 2033. These options vest in three equal installments on May 13, 2027, 2028 and 2029.
The filing also shows 544 common shares withheld at $174.90 per share to cover taxes upon vesting of restricted stock units. This tax withholding was determined by the award terms and not by Scott’s discretion. After these transactions, he directly holds 10,547 Enova common shares.
GOODYEAR WILLIAM M reported acquisition or exercise transactions in this Form 4 filing.
Enova International director William M. Goodyear reported a new equity award and updated holdings. He received 1,320 shares of common stock in the form of Restricted Stock Units that were granted at $0.0000 per share as compensation. All of these RSUs are scheduled to vest on May 13, 2027 if he continues serving on Enova’s board through that date. Following the award, he directly holds 74,971 common shares and indirectly holds 4,000 common shares through the William M. Goodyear 1996 Trust.
Gray James A reported acquisition or exercise transactions in this Form 4 filing.
Enova International, Inc. director James A. Gray reported a stock-based compensation grant and updated share holdings. He received 1,320 shares of common stock in the form of Restricted Stock Units (RSUs) at a stated price of $0.00 per share.
According to the filing, 100% of these RSUs will vest on May 13, 2027, provided he continues to serve on Enova’s board of directors through that date. After this grant, Gray holds 70,029 shares of common stock directly and 10,000 shares indirectly through the James Gray Revocable Trust, with no open-market buys or sells reported in this filing.
Enova International, Inc. director Gregg A. Kaplan reported a compensation-related equity grant. He acquired 1,320 shares of common stock in the form of Restricted Stock Units on May 13, 2026, at a stated price of $0.00 per share. Following this grant, his directly owned stake increased to 44,232 shares. The RSUs are scheduled to vest 100% on May 13, 2027, provided he continues serving as a member of Enova’s board of directors through that date.
RICE LINDA JOHNSON reported acquisition or exercise transactions in this Form 4 filing.
Enova International director Linda Johnson Rice received an equity award in the form of restricted stock units. She was granted 1,320 shares of common stock at no cash cost, increasing her direct holdings to 7,577 shares. The RSUs will vest 100% on May 13, 2027, provided she continues to serve on Enova International, Inc.’s board of directors through that date.
Enova International, Inc. director Mark McGowan reported an equity compensation grant and updated share holdings. He received 1,320 Restricted Stock Units (RSUs) of common stock at $0.0000 per share, classified as a grant or award acquisition. These RSUs vest 100% on May 13, 2027, provided he continues serving on the board as of that date. Following the grant, he holds 47,021 common shares directly and 21,593 shares indirectly through SAF Capital Fund. A footnote states he disclaims beneficial ownership of the SAF Capital Fund shares except to the extent of his pecuniary interest.
Corby Lindsay Y reported acquisition or exercise transactions in this Form 4 filing.
Enova International director Corby Lindsay Y reported an equity compensation grant in the form of 1,320 shares of common stock, reflected as Restricted Stock Units (RSUs). The RSUs will vest 100% on May 13, 2027, provided the grantee continues serving on Enova’s board of directors through that date. Following this award, Corby Lindsay Y holds a total of 4,660 shares of Enova common stock directly.
Enova International’s Chief Strategy Officer Kirk Chartier received a grant of 3,038 non-qualified stock options with a tandem stock appreciation right (SAR). The options carry an exercise price of $166.88 per share and expire on May 13, 2033.
The options vest in roughly equal one-third installments on May 13, 2027, May 13, 2028 and May 13, 2029, contingent on continued employment. The SAR can be exercised only if a Change in Control occurs and a qualifying Offer is made, allowing a cash amount based on the excess of the Offer Value Per Share over the exercise price.
Enova International Executive Chairman David Fisher received a grant of 8,979 non-qualified stock options with a limited stock appreciation right (SAR) on May 13, 2026. The options have an exercise price of $166.88 per share and expire on May 13, 2033.
The award vests in three substantially equal annual installments on May 13 of 2027, 2028 and 2029, contingent on continued employment. The tandem SAR can only be exercised following a defined change in control and is payable only if a qualifying offer for Enova is made.
Enova International, Inc. reported that Chief Executive Officer Steven E. Cunningham received a grant of 10,674 non-qualified stock options with a tandem stock appreciation right. The options carry an exercise price of $166.88 per share and are exercisable for Enova common stock.
The options vest in substantially equal one-third increments on May 13, 2027, May 13, 2028, and May 13, 2029, contingent on continued employment. The award, including the limited stock appreciation right, expires on May 13, 2033 and represents compensation, not an open-market share purchase or sale.
FEEHAN DANIEL R reported acquisition or exercise transactions in this Form 4 filing.
Enova International director Daniel R. Feehan reported new equity compensation in the form of Restricted Stock Units (RSUs). He received a grant of 1,320 shares of common stock at $0.0000 per share as a grant or award. According to the terms, 100% of these RSUs will vest on May 13, 2027, as long as he continues to serve on Enova International, Inc.’s board of directors through that date.
Following this grant, Feehan holds 61,706 shares of Enova common stock directly. He also reports indirect ownership through trusts, including 5,121 shares held by the Feehan Marital Exempt Trust, 80,325 shares held by the Feehan Marital Non-Exempt Trust, and 140,523 shares held by the Feehan Family Trust. The filing does not show any open-market purchases or sales; it mainly reflects this board-related RSU award and the updated share totals.
TEBBE MARK reported acquisition or exercise transactions in this Form 4 filing.
Enova International director Mark Tebbe received a grant of 1,320 shares of common stock in the form of Restricted Stock Units (RSUs). The RSUs will vest in full on May 13, 2027, provided he continues to serve on Enova’s board of directors through that date.
Following this equity award, Tebbe directly holds 70,029 shares of Enova common stock. This grant functions as stock-based compensation, aligning his interests with shareholders by tying additional ownership to ongoing board service.
CARNAHAN ELLEN reported acquisition or exercise transactions in this Form 4 filing.
Enova International director Ellen Carnahan reported an equity award and updated her share holdings. She received a grant of 1,320 shares of common stock in the form of Restricted Stock Units at an effective price of $0.00 per share.
The footnote states that 100% of these RSUs will vest on May 13, 2027, provided she continues to serve on Enova International’s board of directors through that date. Following this award, she directly holds 59,704 shares of common stock and indirectly holds 4,590 shares through the Ellen Carnahan Revocable Living Trust.
Enova International reported that its General Counsel and Secretary, Sean Rahilly, received a grant of 2,108 non-qualified stock options with a limited stock appreciation right, exercisable for common stock at an exercise price of $166.88 per share. The options were granted as compensation and vest in three substantially equal installments on May 13, 2027, May 13, 2028, and May 13, 2029, subject to continued employment. The tandem SAR becomes exercisable only after a qualifying change in control and qualifying offer, and then only for the 30-day period following such change, providing a cash-settlement feature based on the excess of the offer value over the option exercise price.
Enova International Executive Chairman David Fisher sold shares in an open-market transaction. On May 7, 2026, he sold 20,000 shares of common stock at a weighted average price of $173.1784 per share, in multiple trades between $172.00 and $174.18. Following this sale, Fisher directly holds 306,444 Enova shares, indicating he retained a substantial equity position after the transaction.
Enova International CEO Steven E. Cunningham reported an exercise-and-sell stock transaction. He exercised non-qualified stock options for 3,696 shares of common stock at an exercise price of $31.98 per share on April 28, 2026. On the same date, he sold a total of 7,852 shares of common stock in open-market transactions at a price of $175.50 per share. After these trades, he directly owns 122,945 shares of Enova common stock and holds 7,391 non-qualified stock options with an exercise price of $31.98 per share that are scheduled to expire on August 3, 2028.
Enova International, Inc. Chief Executive Officer Steven E. Cunningham filed an amended insider report to correct an earlier administrative error. The amendment adds a previously omitted open-market sale of 3,016 shares of common stock on January 30, 2026 at $165.25 per share. Following inclusion of this sale, his directly held position is reported as 124,703 shares of Enova common stock.
Rahilly Sean reported acquisition or exercise transactions in this Form 4 filing.
Enova International, Inc. reported that General Counsel and Secretary Sean Rahilly received a corrected grant of 9,474 shares of common stock on February 11, 2026 as a restricted stock award at no cost per share. This Form 4 amendment fixes an earlier filing that mistakenly showed only 3,174 shares granted. After the correction, Rahilly is reported to beneficially own a total of 104,249 shares of Enova common stock directly.
Lee James Joseph reported acquisition or exercise transactions in this Form 4 filing.
Enova International, Inc. Chief Accounting Officer Lee James Joseph filed an amended Form 4 to correct an earlier administrative error in a restricted stock grant. The grant consists of 3,723 shares of common stock at a stated price of $0.0000 per share, reflecting a compensation award rather than an open-market purchase. Following this correction, his directly held beneficial ownership is reported as 22,548 common shares.
Enova International, Inc. director James A. Gray, through the James Gray Revocable Trust, reported an amended Form 4 reflecting an open-market sale of 10,000 shares of common stock on February 2, 2026 at a weighted average price of $172.2167 per share. The amendment corrects the originally reported 9,999 shares and prior average price. Following the transaction, the trust is shown as beneficially owning 10,000 shares indirectly.
Enova International Executive Chairman David Fisher reported an open-market sale of 7,143 shares of common stock on February 18, 2026 at a weighted average price of $149.4885 per share. The trade was executed under a pre-arranged Rule 10b5-1 trading plan, and Fisher now holds 326,444 shares directly.
Lee James Joseph reported acquisition or exercise transactions in this Form 4 filing.
Enova International Chief Accounting Officer Lee James Joseph received an equity award of 1,203 shares of common stock on February 11, 2026 as a grant, at a price of $0 per share. After this award, he directly owns 20,028 common shares.
The grant represents restricted stock units that will vest in four substantially equal installments on February 11 of 2027, 2028, 2029, and 2030, so long as he remains an employee of Enova or one of its affiliates through each vesting date.
Enova International, Inc. reported that its General Counsel and Secretary, Sean Rahilly, received equity-based compensation awards. On February 11, 2026, he acquired 3,174 shares of common stock as a grant of restricted stock units at a price of $0 per share, bringing his directly held common stock to 97,949 shares.
He was also granted a non-qualified stock option covering 2,039 shares of common stock at an exercise price of $157.79 per share, together with a limited stock appreciation right granted in tandem. The restricted stock units vest in four equal annual installments from February 11, 2027 through February 11, 2030, while the options vest in three equal annual installments from February 11, 2027 through February 11, 2029 and expire on February 11, 2033.
Enova International’s Chief Financial Officer, Cornelis Scott, reported equity awards granted on February 11, 2026. He acquired 3,276 shares of common stock as a grant of restricted stock units at a price of $0 per share, bringing his directly held common stock to 11,091 shares.
He also received 2,105 non-qualified stock options with a limited stock appreciation right at an exercise price of $157.79 per share, expiring on February 11, 2033. The restricted stock units vest in four equal annual installments starting February 11, 2027, while the options vest in three equal annual installments beginning the same date, subject to continued employment.
Enova International Chief Executive Officer Steven E. Cunningham reported new equity awards. He acquired 16,067 shares of common stock through a grant of restricted stock units at a grant price of $0, bringing his directly held common shares to 130,117.
These restricted stock units vest in four equal annual installments on February 11 of 2027, 2028, 2029 and 2030, contingent on continued employment. He was also granted 10,323 non-qualified stock options with an exercise price of $157.79 per share, expiring on February 11, 2033, which vest in three equal annual installments on February 11 of 2027, 2028 and 2029.
Enova International Executive Chairman David Fisher received new equity awards in the form of common stock and stock options. On February 11, 2026, he was granted 13,515 shares of common stock as restricted stock units at a price of $0 per share, increasing his directly owned common stock to 333,587 shares.
He was also granted 8,684 non-qualified stock options with a limited stock appreciation right at an exercise price of $157.79 per share, leaving him with 8,684 such options outstanding. The 13,515 restricted stock units vest in four equal annual installments from February 11, 2027 through February 11, 2030, while the options vest in three equal annual installments from February 11, 2027 through February 11, 2029.
Enova International’s Chief Strategy Officer Kirk Chartier reported equity awards under the company’s incentive plans. He acquired 4,573 shares of common stock as a grant of restricted stock units at a price of $0 per share, bringing his directly owned common shares to 104,972.
He also received a non‑qualified stock option, paired with a limited stock appreciation right, covering 2,938 shares of common stock at an exercise price of $157.79 per share and expiring on February 11, 2033. The RSUs vest in four equal annual installments from February 11, 2027 through February 11, 2030, while the options vest in three equal annual installments from February 11, 2027 through February 11, 2029, conditioned on continued employment. The SAR becomes exercisable only if a defined change in control and qualifying offer occur.
Enova International’s General Counsel and Secretary, Sean Rahilly, reported routine share withholding transactions related to vesting of restricted stock units. On February 5–8, 2026, the issuer withheld 450, 3,937, 843 and 872 common shares at prices around $159.78–$161.10 to cover taxes. After these transactions, Rahilly directly owned 94,775 Enova common shares.
Enova International, Inc. Executive Chairman and director David Fisher reported several share-withholding transactions related to equity compensation. On February 5, 6, and 8, 2026, Enova withheld blocks of common stock (transaction code F) to cover taxes due upon the vesting of restricted stock units, as described in the footnote. These were not discretionary open-market sales but automatic tax-withholding events determined by the award terms. Following the last reported withholding, Fisher directly beneficially owned 320,072 shares of Enova common stock.
Enova International Chief Executive Officer Steven E. Cunningham reported automatic share withholding transactions by the company to cover taxes due on vesting restricted stock units between February 5 and 8, 2026. These are coded as transaction type F, indicating tax-related payments.
The issuer withheld blocks of common stock at prices around $159.78–$161.10, including 3,870 shares on February 5 and 5,209 shares on February 8. After the final transaction, Cunningham directly beneficially owns 114,050 Enova shares.
Enova International, Inc.'s Chief Financial Officer Cornelis Scott reported several small share disposals that were tax withholdings, not open-market sales. On multiple dates in early February 2026, the company withheld blocks of common stock to cover taxes tied to vested restricted stock units, as required by the award terms. After these automatic withholdings, Scott directly held 7,815 shares of Enova common stock.
Enova International’s Chief Accounting Officer, Lee James Joseph, reported several small share withholdings by the company to cover taxes on vested restricted stock units. On multiple dates in early February 2026, Enova withheld blocks of common stock, including 156 shares at $159.78 and 273, 246, and 251 shares at $161.10 per share. These are coded as tax-related “F” transactions rather than open-market sales, and Joseph continues to hold about 18,825 Enova shares directly afterward.
Enova International Chief Strategy Officer Kirk Chartier reported several automatic share withholdings tied to restricted stock unit vesting. On multiple dates in early February 2026, Enova withheld 795, 1,421, 3,099 and 1,791 common shares to cover taxes at prices around $160 per share. These Form 4 entries are coded as tax-withholding transactions, not open-market sales, and followed the terms of the equity awards rather than the officer’s trading decisions. After the final withholding, Chartier beneficially owned 100,399 Enova common shares directly.
Enova International director-associated trust sells shares while direct holdings remain. On February 2, 2026, the Mark A Tebbe Revocable Trust, an entity associated with director Mark Tebbe, sold 20,000 shares of Enova International common stock at a weighted average price of $172.2412 per share.
These sales were executed in multiple trades at prices between $172.05 and $172.52. Following the reported transactions, Mark Tebbe directly beneficially owned 68,709 shares of Enova International common stock, separate from the trust’s now-disposed position.
Enova International director James A. Gray reported indirect sales of company stock through family trusts. On February 2, 2026, the JG 2002 Delta Trust sold 10,000 shares of Enova common stock at a weighted average price of $171.8632 per share. On the same date, the James Gray Revocable Trust sold 9,999 shares at a weighted average price of $172.2169 per share, leaving it holding 10,001 shares. Separately, Gray is shown as directly owning 68,709 shares of Enova common stock following these reported transactions.